Skip to content
Search

Latest Stories

PSNC chief Simon Dukes steps down; community pharmacy shocked and sorry to see him go

Simon Dukes has announced that he will be resigning his post as chief executive of the Pharmaceutical Services Negotiating Committee at the end of September.

In a statement this afternoon (July 20), PSNC said it has already been looking for a new CEO to "lead the organisation from October 2021" after Dukes decided to step down.


Dukes, who joined PSNC in 2018 from counter-fraud organisation Cifas, said: "Deciding to step down was never going to be easy, but I do believe now is opportune."

Sector shocked and sorry to see Dukes go

Often described as by pharmacy insiders as "a breath of fresh air" when he joined PSNC to replace Sue Sharpe who led the organisation for 16 years, Dukes' resignation has shocked the community pharmacy sector.

"This is a very sad news," said Bharat Shah, founder of Sigma Pharmaceuticals, giving his reaction. He added that it was going to be a huge loss for community pharmacy, particularly at this very ‘critical time’.

"Simon has done so much for community pharmacy in the last few years and just recently got an agreement from DHSC to compensate contractors for the extra costs they incurred during the pandemic."

"Sorry to see him go," said Graham Phillips, award-wining community pharmacist and owner of Manor Pharmacy.

"He was a real breath of fresh air and was starting to make a difference not least the fundamental reform of PSNC and a credible relationship with government and the NHS."

Malcolm Harrison, CEO of Company Chemists' Association, said Dukes' departure would leave the PSNC with some very big shoes to fill.

“Simon has achieved much during his three years at the helm of PSNC and shown a real commitment to community pharmacy. I and everyone at the CCA wish him all the very best for the future."

PSNC’s appointments panel has already met to begin a recruitment process for the critical role which comes at a time of change for both PSNC and the LPCs as the new CEO will have to oversee an intense period of negotiations for the sector.

"We will shortly be commencing a rigorous selection programme to find Simon’s replacement," PSNC chair Sue Killen, said.

Dukes has steered PSNC and community pharmacy through a critical period, including leading negotiations that led to the agreement of the five-year national contract CPCF as well as driving the organisation's work to support contractors through the Covid-19 pandemic.

According to a statement, Dukes will remain in post until the end of September and continue to head up PSNC’s negotiating team, leading its work to agree the arrangements for Year 3 of the five-year CPCF deal.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less